TCM | Antitumor inflammatory microenvironment effects | Types of cancer | Cancer models | References | |
---|---|---|---|---|---|
Chinese herbal components | Icaritin | ↓IL-6/JAK2/STAT3 signaling pathway | Multiple myeloma | MM xenograft mouse models | [106] |
Ginsenoside Rb1 | ↓TNF-α and IL-6 | Cancer cachexia | C26 cancer cachexia mouse | [107] | |
Notoginsenoside R1 | ↓IL-6↓JAK2/STAT3 signaling pathway | Osteosarcoma | U2OS osteosarcoma cells | [108] | |
Astragaloside | ↓IL-6/STAT3 signaling pathway ↓IL-6R, STAT3, survivin, and cyclin D1 | Colitis-associated cancer in mice | AOM/DSS mouse model | [109] | |
Platycodin D (PD) | ↑IL-2, IL-6, TNF-α and IFN-γ | H22 hepatocellular carcinoma | Murine solid tumours H22 transplanted model | [110] | |
Esculentoside A (EsA) | ↓ALDH1A1, Sox2, and Oct4↑proapoptotic proteins, Bax and cleaved caspase-3↓Bcl‐2↓IL‐6/STAT3 pathway | Breast cancer | Murine breast CSCs (EMT6M) | [111] | |
Icariin (ICA) | ↓TGF-β1, TNF-α, IL-6, IL-17A, IL-10↓Ki67, survivin, Bcl-2, c-Myc↑P16, P53, Bax | Cervical cancer | Mice bearing U14 cervical tumour | [112] | |
Aloe emodin | ↓JNK↓IL-1β and IL-6↓VEGF and MMP | Breast cancer | 4T1 breast cancer cells | [113] | |
Osthole | ↓MMP-9 and vimentin | Liver cancer | Human liver cancer HepG2 cells | [114] | |
Osthole | ↓M0-M2↓MRC1, CCL22 and TGF-β↓p-STAT6 and the p-ERK1/2-C/EBP b axis | Pancreatic cancer | C57BL/6 mice model | [114] | |
Matrine | ↑IFN-γ/TNF-αand IL-p70 | Human gastric carcinoma | The cytotoxic T lymphocyte (CTL) | [115] | |
β-Glycyrrhetinic acid | ↓I-κBα和NF-κB↓TNF-α | – | RAW 264.7 cell | [116] | |
Baicalin | ↓MMP- 2 and MMP- 9↑TIMP- 2↓TLR4, p- IκBα, and NF- κB p65↓TLR4/NF- κB signaling pathway | Colorectal cancer (CRC) | Subcutaneous xenograft tumour mouse model of CT26 cells | [117] | |
Curcumin | ↓MDSCs↓TLR4/NF κB signaling pathway↓IL 6, IL 1β, prostaglandin E2 and COXe 2 | Liver cancer | HepG2 xenograft model | [118] | |
Curcumin | ↓NF-κB↑TRAIL receptors↑peripheral mononuclear neutrophils | Bladder cancer | MBT-2 murine tumour models | [119] | |
Tanshinone IIA, xanthohumol, and curcumin | ↓PI3K/AKT signaling pathway, BCL6, VEGF | Glioma | – | [120] | |
Matrine | ↓PI3K/AKT/mTOR signaling pathway | Lung cancer | A549 and 95D lung cancer cells | [121] | |
Chinese herbal formula | Empirical formula for clearing heat and detoxification | ↓TAMs | Endometrial cancer | Xenograft tumor of endometrial carcinoma | [79] |
Taohong Siwu decoction | ↓EMT | Breast cancer | HER-2+ breast cancer | [122] | |
Eight-treasure decoction | ↓hs-CRP, ↓IL-6, IL-8 | Breast cancer | – | [123] | |
Huatan Tongyu Jiedu recipe | ↓Micro-vessel density and ↓VEGF | – | Mice bearing S180 transplanted tumor | [124] | |
Huatan Xiaoliu decoction | ↓VEGF, ↑nm23 mRNA | Lung cancer | Lewis tumor-bearing mice | [77] | |
Xiaotan Sanjie decoction | ↑RUNX3↓NF-κB p65 | Gastric cancer | Human gastric cancer cell SGC-7901-bearing nude mice | [125] | |
Huayu Jiedu Tongluo recipe | ↓COX-2↑PGI, G-17; ↓IL-1β, IL-8, TNF-α | Stomach cancer | Stomach-collateral stasis-toxin type gastric precancerous lesion | [126] | |
Yiqi Huayu Jiedu prescription | ↓HIF-1α, VM | Hepatocellular carcinoma | Human hepatocellular carcinoma sorafenib resistant cells in nude mice | [127] | |
Modified Huangqi Jianzhong decoction | ↓CXCL12/CXCR4 signaling pathway | Lung cancer | Mice bearing Lewis lung cancer with syndrome of spleen qi deficiency | [78] | |
Shanxian granule | ↓VEGF, MVD | Liver cancer | Liver cancer of qi-deficiency and blood-stasis | [128] |